171 related articles for article (PubMed ID: 26384530)
1. The emerging roles of F-box proteins in pancreatic tumorigenesis.
Wang H; Maitra A; Wang H
Semin Cancer Biol; 2016 Feb; 36():88-94. PubMed ID: 26384530
[TBL] [Abstract][Full Text] [Related]
2. Fbxw7 Deletion Accelerates Kras
Zhang Q; Zhang Y; Parsels JD; Lohse I; Lawrence TS; Pasca di Magliano M; Sun Y; Morgan MA
Neoplasia; 2016 Nov; 18(11):666-673. PubMed ID: 27764699
[TBL] [Abstract][Full Text] [Related]
3. Regulation of GSK3β-FBXW7-JUNB axis.
Pérez-Benavente B; Farràs R
Oncotarget; 2013 Jul; 4(7):956-7. PubMed ID: 23918007
[No Abstract] [Full Text] [Related]
4. Tumor suppressor Fbxw7 antagonizes WNT signaling by targeting β-catenin for degradation in pancreatic cancer.
Jiang JX; Sun CY; Tian S; Yu C; Chen MY; Zhang H
Tumour Biol; 2016 Oct; 37(10):13893-13902. PubMed ID: 27485116
[TBL] [Abstract][Full Text] [Related]
5. Thiazolidinediones modulate the expression of beta-catenin and other cell-cycle regulatory proteins by targeting the F-box proteins of Skp1-Cul1-F-box protein E3 ubiquitin ligase independently of peroxisome proliferator-activated receptor gamma.
Wei S; Lin LF; Yang CC; Wang YC; Chang GD; Chen H; Chen CS
Mol Pharmacol; 2007 Sep; 72(3):725-33. PubMed ID: 17569795
[TBL] [Abstract][Full Text] [Related]
6. Tumor-suppressor Fbxw7 targets SIK2 for degradation to interfere with TORC2-AKT signaling in pancreatic cancer.
Zhang MX; Wang H; Sun GP
Cell Biol Int; 2020 Sep; 44(9):1900-1910. PubMed ID: 32437091
[TBL] [Abstract][Full Text] [Related]
7. ERK kinase phosphorylates and destabilizes the tumor suppressor FBW7 in pancreatic cancer.
Ji S; Qin Y; Shi S; Liu X; Hu H; Zhou H; Gao J; Zhang B; Xu W; Liu J; Liang D; Liu L; Liu C; Long J; Zhou H; Chiao PJ; Xu J; Ni Q; Gao D; Yu X
Cell Res; 2015 May; 25(5):561-73. PubMed ID: 25753158
[TBL] [Abstract][Full Text] [Related]
8. Regulating Fbw7 on the road to cancer.
Xu W; Taranets L; Popov N
Semin Cancer Biol; 2016 Feb; 36():62-70. PubMed ID: 26459133
[TBL] [Abstract][Full Text] [Related]
9. Cell cycle-dependent degradation of the methyltransferase SETD3 attenuates cell proliferation and liver tumorigenesis.
Cheng X; Hao Y; Shu W; Zhao M; Zhao C; Wu Y; Peng X; Yao P; Xiao D; Qing G; Pan Z; Yin L; Hu D; Du HN
J Biol Chem; 2017 Jun; 292(22):9022-9033. PubMed ID: 28442573
[TBL] [Abstract][Full Text] [Related]
10. The CUL7/F-box and WD repeat domain containing 8 (CUL7/Fbxw8) ubiquitin ligase promotes degradation of hematopoietic progenitor kinase 1.
Wang H; Chen Y; Lin P; Li L; Zhou G; Liu G; Logsdon C; Jin J; Abbruzzese JL; Tan TH; Wang H
J Biol Chem; 2014 Feb; 289(7):4009-17. PubMed ID: 24362026
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of SCF ubiquitin ligases by engineered ubiquitin variants that target the Cul1 binding site on the Skp1-F-box interface.
Gorelik M; Orlicky S; Sartori MA; Tang X; Marcon E; Kurinov I; Greenblatt JF; Tyers M; Moffat J; Sicheri F; Sidhu SS
Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3527-32. PubMed ID: 26976582
[TBL] [Abstract][Full Text] [Related]
12. Distinct Interactions of EBP1 Isoforms with FBXW7 Elicits Different Functions in Cancer.
Wang Y; Zhang P; Wang Y; Zhan P; Liu C; Mao JH; Wei G
Cancer Res; 2017 Apr; 77(8):1983-1996. PubMed ID: 28209614
[TBL] [Abstract][Full Text] [Related]
13. Emerging roles for the FBXW7 ubiquitin ligase in leukemia and beyond.
Kourtis N; Strikoudis A; Aifantis I
Curr Opin Cell Biol; 2015 Dec; 37():28-34. PubMed ID: 26426760
[TBL] [Abstract][Full Text] [Related]
14. Deregulation of F-box proteins and its consequence on cancer development, progression and metastasis.
Heo J; Eki R; Abbas T
Semin Cancer Biol; 2016 Feb; 36():33-51. PubMed ID: 26432751
[TBL] [Abstract][Full Text] [Related]
15. The Fbw7 and betaTRCP E3 ubiquitin ligases and their roles in tumorigenesis.
Lau AW; Fukushima H; Wei W
Front Biosci (Landmark Ed); 2012 Jun; 17(6):2197-212. PubMed ID: 22652772
[TBL] [Abstract][Full Text] [Related]
16. The ubiquitin-specific protease USP47 is a novel beta-TRCP interactor regulating cell survival.
Peschiaroli A; Skaar JR; Pagano M; Melino G
Oncogene; 2010 Mar; 29(9):1384-93. PubMed ID: 19966869
[TBL] [Abstract][Full Text] [Related]
17. Wnt/β-catenin signaling inhibits FBXW7 expression by upregulation of microRNA-770 in hepatocellular carcinoma.
Wu WJ; Shi J; Hu G; Yu X; Lu H; Yang ML; Liu B; Wu ZX
Tumour Biol; 2016 May; 37(5):6045-51. PubMed ID: 26602384
[TBL] [Abstract][Full Text] [Related]
18. Genistein down-regulates miR-223 expression in pancreatic cancer cells.
Ma J; Cheng L; Liu H; Zhang J; Shi Y; Zeng F; Miele L; Sarkar FH; Xia J; Wang Z
Curr Drug Targets; 2013 Sep; 14(10):1150-6. PubMed ID: 23834147
[TBL] [Abstract][Full Text] [Related]
19. The FBXW7 beta-form is suppressed in human glioma cells.
Gu Z; Inomata K; Ishizawa K; Horii A
Biochem Biophys Res Commun; 2007 Mar; 354(4):992-8. PubMed ID: 17274947
[TBL] [Abstract][Full Text] [Related]
20. Dosage and tumour suppression.
Berger AH; Knudson AG; Pandolfi PP
J Pathol; 2012 Jun; 227(2):e1; author reply e2. PubMed ID: 22488586
[No Abstract] [Full Text] [Related]
[Next] [New Search]
